首页|The Role of Pituitary Adenylate Cyclase-Activating Polypeptide and Vasoactive Intestinal Peptide in Migraine Pathogenesis

The Role of Pituitary Adenylate Cyclase-Activating Polypeptide and Vasoactive Intestinal Peptide in Migraine Pathogenesis

扫码查看
In this review, we summarize the experimental and clinical data supporting the role of pituitary adenylate cyclase-activating peptide (PACAP) and vasoactive intestinal peptide (VIP) in the pathophysiology of primary headaches, including migraine. We provide evidence of the involvement of these mediators and their receptors in nociception and vascular tone regulation, especially within the trigeminovascular system. The anticephalalgic potential of pharmacological agents blocking the PACAP-ergic pathway is also discussed.

headachemigrainetrigeminal nervepituitary adenylate cyclase-activating polypeptide (PACAP)vasoactive intestinal peptide (VIP)MIDDLE MENINGEAL ARTERYPERIPHERAL-BLOODMAST-CELLSVIP LEVELSPACAPHEADACHENOCICEPTIONMICECGRPRECEPTORS

Sokolov, A. Y.、Osipchuk, A. V.、Skiba, I. B.、Amelin, A. V.

展开 >

Valdman Inst Pharmacol,Pavlov First St Petersburg State Med Univ

Dept Neurol,Pavlov First St Petersburg State Med Univ

2022

Neurochemical journal

Neurochemical journal

SCI
ISSN:1819-7124
年,卷(期):2022.16(1)
  • 104